STOCK TITAN

Vertex to Participate in the Wells Fargo Healthcare Conference on Friday, September 9

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Vertex Pharmaceuticals (NASDAQ: VRTX) announced participation in a fireside chat at the Wells Fargo Healthcare Conference on September 9, 2022, at 11:00 a.m. ET.

A live webcast of the event will be available on the company's website under the 'Investors' section. Vertex is a biotechnology company focusing on transformative medicines for serious diseases, notably cystic fibrosis, and has a strong pipeline addressing various genetic and chronic conditions.

Positive
  • None.
Negative
  • None.

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will participate in a fireside chat at the Wells Fargo Healthcare Conference on Friday, September 9, 2022 at 11:00 a.m. ET.

A live webcast of management’s remarks will be available through Vertex’s website, www.vrtx.com in the “Investors” section under the “News and Events” page. A replay of the conference webcasts will be archived on the company’s website.

About Vertex
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule, cell and genetic therapies in other serious diseases where it has deep insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, pain, type 1 diabetes, alpha-1 antitrypsin deficiency and Duchenne muscular dystrophy.

Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston's Innovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 12 consecutive years on Science magazine's Top Employers list and one of the 2021 Seramount (formerly Working Mother Media) 100 Best Companies. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

(VRTX-WEB)

Vertex Pharmaceuticals Incorporated Investors:

Manisha Pai, 617-961-1899

Miroslava Minkova, 617-341-6135

Source: Vertex Pharmaceuticals Incorporated

FAQ

What event is Vertex Pharmaceuticals participating in on September 9, 2022?

Vertex Pharmaceuticals will participate in the Wells Fargo Healthcare Conference on September 9, 2022.

What time is Vertex's fireside chat during the Wells Fargo Conference?

Vertex's fireside chat is scheduled for 11:00 a.m. ET on September 9, 2022.

Where can I watch the live webcast of Vertex's conference participation?

The live webcast can be accessed through Vertex's website under the 'Investors' section.

What is Vertex Pharmaceuticals known for?

Vertex Pharmaceuticals is known for creating transformative medicines for serious diseases, particularly cystic fibrosis.

What pipeline does Vertex Pharmaceuticals have?

Vertex has a pipeline focused on various serious diseases, including sickle cell disease and type 1 diabetes.

Vertex Pharmaceuticals Inc

NASDAQ:VRTX

VRTX Rankings

VRTX Latest News

VRTX Stock Data

118.29B
257.53M
0.09%
95.96%
1.66%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BOSTON